During the past decade, Tower Cancer Research Foundation conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 28 clinical trials were completed, i.e. on average, 215.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 6 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tower Cancer Research Foundation" #1 sponsor was "National Cancer Institute (NCI)" with 23 trials, followed by "Amgen" with 5 trials sponsored, "Celgene" with 4 trials sponsored, "City of Hope Medical Center" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tower Cancer Research Foundation" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "National Comprehensive Cancer Network" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Tower Cancer Research Foundation" are "Multiple Myeloma" (6 trials), "Lymphoma" (5 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Uterine Carcinosarcoma" (3 trials) and "Adenocarcinoma of the Pancreas" (2 trials). Many other conditions were trialed in "Tower Cancer Research Foundation" in a lesser frequency.

Most popular intervention types in "Tower Cancer Research Foundation" are "Drug" (66 trials), "Other" (20 trials), "Biological" (12 trials), "Procedure" (8 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (8 trials), "Quality-of-Life Assessment" (5 trials), "Questionnaire Administration" (5 trials), "Biospecimen Collection" (4 trials) and "Dexamethasone" (4 trials). Other intervention names were less common.

The vast majority of trials in "Tower Cancer Research Foundation" are 60 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Tower Cancer Research Foundation". undefined are not yet recruiting, 10 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Tower Cancer Research Foundation, 2 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Tower Cancer Research Foundation, 10 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".